Glioblastoma Multiforme Drug Market worth $~880 million by 2027
The report "Glioblastoma Multiforme Drug Market by Therapy (Chemotherapy, Immunotherapy), Drug Class, End Use, Region (North America, Europe, Asia Pacific, and Rest of the World) – Global Forecast to 2027" global glioblastoma multiforme drug market is projected to reach USD ~880 million by 2027 from USD 600 million in 2022, at a CAGR of 8% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/glioblastoma-multiforme-drug-market-167537708.html
Factors such as the rising prevalence of glioblastoma multiforme, increased research & development investments in the space, and favorable regulatory environments will drive the market growth of glioblastoma multiforme drug market over the forecast period.
The chemotherapy segment accounted for the largest share of the glioblastoma multiforme drug market in 2021.
Based on therapy, the glioblastoma multiforme drug market is segmented into chemotherapy, targeted therapy, and immunotherapy. In 2021, the chemotherapy segment accounted for the largest share of the glioblastoma multiforme drug market. In addition to chemotherapy and surgery, radiation therapy may be suggested as the first line of treatment. In the event of a recurrence, it is also highly effective and advised for brain tumors. The tumor is more susceptible to radiation when temozolomide is added to radiotherapy. Radiation therapy with temozolomide is more efficient than radiation alone.
North America to command the largest share of the glioblastoma multiforme drug market in 2021
Based on region, the glioblastoma multiforme drug market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. North America accounted for the largest share of the glioblastoma multiforme drug market in 2021. Some of the key factors attributable for the largest market share are government support for the growth of the healthcare industry, as well as high awareness of rare conditions, easy access to high-quality medical facilities, and favorable reimbursement policies.
Prominent players in the glioblastoma multiforme drug market include Merck & Co., Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer, Inc. (US), Amgen, Inc. (US), Arbor Pharmaceuticals LLC (US), Amneal Pharmaceuticals (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Glioblastoma Multiforme Drug Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
